National Health Act 1953 Amendment special arrangements under subsection 100(1) Chemotherapy Pharmaceuticals Access Program (No. PB 50 of 2010) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 50 of 2010

Amendment special arrangements under subsection 100(1) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Access and Systems Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.

Dated    15 May 2010

LINDA JACKSON

Assistant Secretary

Access and Systems Branch

Department of Health and Ageing

Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program

1              Commencement

This instrument commences on 1 June 2010.

2              Amendment of PB 55 of 2009

Schedule 1 amends PB 55 of 2009.

Schedule 1   Amendments

[1]      Schedule 2, item dealing with Cetuximab

omit from the columns in the order indicated:

Solution for I.V. infusion 100 mg in 50 mL Injection 1 . . Erbitux

[2]      Schedule 3, item dealing with Cetuximab

omit from the columns in the order indicated:

Solution for I.V. infusion 100 mg in 50 mL In compliance with authority procedures set out in paragraph 14: Continuing treatment of stage III, IVa or IVb squamous cell cancer of the larynx, oropharynx or hypopharynx, in combination with radiotherapy, where cisplatin is either contraindicated or not tolerated Injection 1 6 Erbitux